Related Experiment Video
Updated: Jun 12, 2025
Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
Published on: October 15, 2021
Multi-Omic Approaches in Cancer-Related Micropeptide Identification
Katarina Vrbnjak1, Raj Nayan Sewduth1
1VIB-KU Leuven Center for Cancer Biology (VIB), 3000 Leuven, Belgium.
Abstract:
Despite the advances in modern cancer therapy, malignant diseases are still a leading cause of morbidity and mortality worldwide. Conventional treatment methods frequently lead to side effects and drug resistance in patients, highlighting the need for novel therapeutic approaches. Recent findings have identified the existence of non-canonical micropeptides, an additional layer of the proteome complexity, also called the microproteome. These small peptides are a promising class of therapeutic agents with the potential to address the limitations of current cancer treatments. The microproteome is encoded by regions of the genome historically annotated as non-coding, and its existence has been revealed thanks to recent advances in proteomic and bioinformatic technology, which dramatically improved the understanding of proteome complexity. Micropeptides have been shown to be biologically active in several cancer types, indicating their therapeutic role. Furthermore, they are characterized by low toxicity and high target specificity, demonstrating their potential for the development of better tolerated drugs. In this review, we survey the current landscape of known micropeptides with a role in cancer progression or treatment, discuss their potential as anticancer agents, and describe the methodological challenges facing the proteome field of research.
Insights
Novel micropeptides, encoded by non-coding DNA, show promise as targeted, low-toxicity cancer therapeutics. These micropeptides offer a potential solution to limitations of current cancer treatments, including side effects and drug resistance.
Area of Science:
- Molecular Biology
- Proteomics
- Genomics
- Cancer Research
Background:
- Malignant diseases remain a leading cause of global mortality, with conventional therapies facing challenges like side effects and drug resistance.
- Recent advances in proteomic and bioinformatic technologies have uncovered the microproteome, a previously unrecognized layer of proteome complexity.
- This microproteome consists of non-canonical micropeptides encoded by genomic regions historically deemed non-coding.
Purpose of the Study:
- To review the current understanding of micropeptides involved in cancer progression and treatment.
- To discuss the therapeutic potential of micropeptides as novel anticancer agents.
- To highlight the methodological challenges in micropeptide research.
Main Methods:
- Literature review of existing studies on micropeptides in cancer.
- Analysis of proteomic and bioinformatic data identifying micropeptides.
- Evaluation of biological activity, toxicity, and target specificity of known micropeptides.
Main Results:
- Micropeptides have demonstrated biological activity across various cancer types.
- These small peptides exhibit low toxicity and high target specificity, suggesting potential for improved drug development.
- The discovery of the microproteome expands our understanding of genome function and proteomic diversity.
Conclusions:
- Micropeptides represent a promising new class of therapeutic agents for cancer treatment.
- Their unique characteristics offer potential advantages over conventional cancer therapies.
- Further research and technological advancements are needed to overcome challenges in micropeptide discovery and application.
More Related Videos
08:08Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
10:37Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
Published on: November 15, 2017
Related Concept Videos
01:33Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
01:33Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...